莎普爱思：获得左氧氟沙星滴眼液药品补充申请批准

Group 1 - The company, Shapuaisi (603168), has received the approval notice for the supplementary application of Levofloxacin Eye Drops from the National Medical Products Administration [1] - The drug is indicated for bacterial infections including Staphylococcus and Streptococcus, with applications for conditions such as blepharitis and conjunctivitis [1] - The company has invested approximately 5.93 million yuan in the research and development of this product, which is expected to enhance its market competitiveness [1]